This article reviews the synthetic routes and final crystalline forms of the recently approved oncology drugs capmatinib, selpercatinib, and pralsetinib. The patent literature served as the primary source of information.

中文翻译：

---

肿瘤药物 Capmatinib、Selpercatinib 和 Pralsetinib 的合成途径和晶型综述

本文回顾了最近批准的肿瘤药物卡马替尼、selpercatinib 和 pralsetinib 的合成路线和最终晶型。专利文献是主要的信息来源。